期刊文献+

高效液相色谱法测定人血浆中氨磺必利的浓度 被引量:4

Determination of amisulpride in plasma by HPLC with UV detection
下载PDF
导出
摘要 目的:建立测定人血浆中氨磺必利浓度的高效液相色谱法。方法:以DiamonsilTMC18(150mm×4.6mm,5μm)为色谱柱,流动相为0.03mol.L-1磷酸二氢钾(调pH6.4)-乙腈(82∶18),流速为1.0mL.min-1,柱温40℃,检测波长为275nm。以醋酸乙酯-二氯甲烷(80∶20)为提取剂。结果:氨磺必利1000.0,400.0,10.0μg.L-13种质量浓度平均回收率分别为97.63%,98.71%,100.29%,日内、日间差RSD均低于8%(n=5);分析方法的最低检测浓度为10.0μg.L-1;线性范围10.0~1000.0μg.L-1。回归方程C=136.03F-3.25,r=0.9996(n=9)。结论:本法灵敏、准确、简单、快速,可用于临床血药浓度监测和药动学研究。 OBJECTIVE To establish a method for determining the plasma concentration of amisulpride by HPLC. METHODS Amisulpride was extracted with diethyl ether. The residues were analyzed by a reverse phase HPLC system with Diamonsil Ca8 column (150 mm×4. 6 mm,5μm), the mobile phase consisted of 0. 03 mol·L^-1 Postassium dihydrogen phosphate(pH6. 4)-acetonitrile (82 : 18) the detection wavelength was at 275 nm. RESULTS The average recoveries of amisulpride were 97. 63 %, 98. 71% and 100. 29%, respectively. The within-day and between-day precision of variation was less than 8 %. The calibration curves of arnisulpride ranged from 10. 0-1 000. 0μg·L^-1 had good linearity,r= 0. 999 6(n= 9). The limits of quantitation for amisulpride was 10.0 μg·L^-1. CONCLUSION The method provides a sensitive, accurate, precise and reliable analytical procedure for clinical monitoring of amisulpride in plasma and its pharmacokinetic studies.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第9期1192-1194,共3页 Chinese Journal of Hospital Pharmacy
基金 广东省医学科研基金资助项目(编号:B2003128)
关键词 氨磺必利 血药浓度 高效液相色谱法 amisulpride plasma concentration HPLC
  • 相关文献

参考文献6

  • 1Timoth JR,Lambert,David J.Castle.Pharmacological approaches to the management of schizophrenia[J].MJA Vol,May,2003,178:5.
  • 2沈一峰,李华芳,顾牛范.新型抗精神病药氨磺必利[J].中国临床药学杂志,2000,9(2):123-126. 被引量:51
  • 3Sachse J,Hartter S,Weigmann H,et al.Automated determination of amisulpride by liquid chromatography with column switching and spectrophotometric detection[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,784(2):405-410.
  • 4Pehourcq F,Ouariki S,Begaud B.Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma:application to manage acute intoxication[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,789(1):101-105.
  • 5Ascalone V,Ripamonti M,Malavasi B.Stereospecific determination of amisulpride,a new benzamide derivative,in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column.Application to pharmacokinetics[J].J Chromatogr B Biomed Appl,1996,676(1):95-105.
  • 6Bergemann N,Kopitz J,Kress KP,Frick A.Plasma amisulpride levels in schizophrenia or schizoaffective disorder[J].Eur Neuropsychopharmacol,2004,14(3):245-250.

二级参考文献15

  • 1[1]Schoemaker H,Claustre Y,Fage D,et al.Neurochemical character- ristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.J Pharmacol Exp Ther,1997,280(1):83
  • 2[2]Cudennec A,Fage D,Benavides J,et al.Effects of amisulpride,an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors,on integrated functional cerebral activity in the rat.Brain Rec,1997,768(1-2):257
  • 3[3]Trichard C,Paillere-Martinot ML,Attar-Levy D,et al.Binding of antipsychotic drugs to cortical 5-HT2A receptors:a PET sutdy of chlorpromazine,clozapine,and amisulpride in schizophrenic patients.Am J Psychiatry,1998,155(4):505
  • 4[4]Hamon-Vilcot B,Chaufour S,Deschamps C,et al.Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.Eur J Clin Pharmacol,1998,54(5):405
  • 5[5]Chabannes JP,Pelissolo A,Farah S,et al.Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses.Encephale,1998,24(4):386
  • 6[6]Puech A,Fleurot O,Rein W.Amisulpride,and atypical antipsychotic,in the treatment of acute episodes of schizophrenia:a dose-ranging study vs haloperidol.Acta Psychiatr Scand,1998,98(1):66
  • 7[7]Wetzel H,Grunder G,Hillert A,et al.Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology-a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist.Psychopharmacology(Berl),1998,137(3):223
  • 8[8]Rein W,Turjanski S.Clinical update on amisulpride in deficit schizophrenia.Int Clin Psychopharmacol,1997,12(Suppl)2:19
  • 9[9]Danion JM, Rein W, Fleurot O. Improvements of schizophrenic patients with primary negative symptoms treated with amisulpride. Am J Psychiatry, 1999, 156(4):610
  • 10[10]Ravizza L.Amisulpride in medium-term treatment of dysthymia a six-month,double blind safety study versus amitriptyline.J psychopharmacol,1999,13(3):248

共引文献50

同被引文献31

  • 1黄继伟,吕维忠,何益群.氨磺必利与利培酮治疗首发精神分裂症对照研究[J].临床心身疾病杂志,2013,19(4):343-313. 被引量:39
  • 2袁洞君,阳利龙,祝文兵,何周康.HPLC法测定人血浆中舒必利浓度及其人体药动学和相对生物利用度研究[J].儿科药学杂志,2006,12(3):4-6. 被引量:6
  • 3Rosenzweg P, Canal M, Patat A, et al. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers [ J ]. Hunt Psychopharmacol Clin Exp, 2002 ; 17 : 1 - 13.
  • 4Gschwend MH, Arnold P, Ring J, et al. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionization and muhiple reaction monitoring[ J]. J Chromatogr B, 2006; 831: 132 - 139.
  • 5Pehourcq F, Ouariki S, Begaud B. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication[ J]. J Chromatogr B, 2003; 789:101 -105.
  • 6穆殿平,刘新.卡马西平健康人体药物动力学特性[J].中国药师,2007,10(10):960-962. 被引量:3
  • 7Fatma VT, Taner G. Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders [ J ]. Europ Child Adoles Psy- chiatry,2009,18:511 -513.
  • 8Torta R, Berra C, Binaschi L, et al. Amisulpride in the short -term treat- ment of depressive and physical symptoms in cancer patients during chemotherapies[ J]. Supportive Care Cancer,2007,15:539 - 546.
  • 9Chen JH, Tzeng NS. Successful Treatment With Amisulpride for Post stroke Psychosis[ J]. J Neuropsychiatry ,2010,22:352 - 353.
  • 10Nirogi R, Bhyrapuneni G, Kandikere V, et al. Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride- with LLOQ of 100 pg/ml using 100 μl of plasma[ J]. Biomed Chroma- tography,2008,22 : 1424 - 1433.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部